Hypertensive iridocyclitis.
Kim EC, Margolis TP.
Br J Ophthalmol. 2006 Jul;90(7):812-3. doi: 10.1136/bjo.2006.091876.
Fuchs' heterochromic iridocyclitis.
Schwab IR.
Int Ophthalmol Clin. 1990 Fall;30(4):252-6. doi: 10.1097/00004397-199030040-00004.
Coccidioidomycosis iridocyclitis.
Moorthy RS, Rao NA, Sidikaro Y, Foos RY.
Ophthalmology. 1994 Dec;101(12):1923-8. doi: 10.1016/s0161-6420(94)31082-7.
Effect of serum metabolites on the risk of iridocyclitis: a bidirectional Mendelian randomization study.
Zou X, Lu Y, Tan Y.
Sci Rep. 2024 May 8;14(1):10535. doi: 10.1038/s41598-024-61441-4.
Polychromasia capsulare in Fuchs heterochromic iridocyclitis: case report and literature review.
Morfeq H, Jany B, Morfeq A, Mahmood S, Boucenna W, Milazzo S.
Can J Ophthalmol. 2020 Dec;55(6):e215-e216. doi: 10.1016/j.jcjo.2020.05.012. Epub 2020 Aug 18.
Fuchs heterochromic iridocyclitis and the rubella virus.
Liu Y, Takusagawa HL, Chen TC, Pasquale LR.
Int Ophthalmol Clin. 2011 Fall;51(4):1-12. doi: 10.1097/IIO.0b013e31822d6923.
Prescription glucocorticoid medication and iridocyclitis are associated with an increased risk of senile cataract occurrence: a Mendelian randomization study.
Wen R, Xi YJ, Zhang R, Hou SJ, Shi JY, Chen JY, Zhang HY, Qiao J, Feng YQ, Zhang SX.
Aging (Albany NY). 2024 Jun 26;16(12):10563-10578. doi: 10.18632/aging.205963. Epub 2024 Jun 26.
Iris nodules in Fuchs heterochromic iridocyclitis.
Shaikh N, Kumar V, Venkatesh P.
Indian J Ophthalmol. 2019 Aug;67(8):1339. doi: 10.4103/ijo.IJO_2105_18.
Fuchs heterochromic iridocyclitis--syndrome, disease, or both?
Cunningham ET Jr, Baglivo E.
Am J Ophthalmol. 2009 Oct;148(4):479-81. doi: 10.1016/j.ajo.2009.06.007.
Lepromatous iridocyclitis.
Citirik M, Batman C, Aslan O, Adabag A, Ozalp S, Zilelioglu O.
Ocul Immunol Inflamm. 2005 Feb;13(1):95-9. doi: 10.1080/09273940490912380.
